XWELL Pays $2.7M to Buy Out XpresTest Restricted Stock Ahead of $13M Sale
XWEL has more than doubled off its 52-week low of $0.255.
Summary
XWELL repurchased all 279.5 XpresTest restricted stock awards for $2.7 million, paying Chairman Bernstein $1.03M, CEO Ernst $529,875, and CFO Brown $96,341, clearing the subsidiary's cap table before the $13M asset sale.
Key Events · M&A and Partnerships · XWEL
-
XpresTest RSA Repurchase Completed
XpresTest repurchased 279.5 restricted stock awards for approximately $2.7 million at $9,634.09 per share, with all unvested RSAs becoming fully vested.
-
Insider Payouts Disclosed
Chairman Bruce Bernstein received $1,030,847.61 for 107 RSAs; CEO Ezra Ernst received $529,874.94 for 55 RSAs; CFO Ian Brown received $96,340.90 for 10 RSAs.
-
Cap Table Simplified for Sale
No XpresTest RSAs remain outstanding and XWELL now owns 100% of XpresTest, clearing the subsidiary's capitalization ahead of the pending $13 million sale.
-
Sale Proceeds Impact
Because the $2.7 million was paid early, these amounts will not be deducted from the purchase price payable by the Buyer at closing, preserving the full $13 million sale consideration.
Analysis · XWEL · Trade & Services
XWELL accelerated the repurchase of all outstanding XpresTest restricted stock awards, paying approximately $2.7 million at $9,634.09 per share. Chairman Bruce Bernstein received $1.03 million, CEO Ezra Ernst received $529,875, and CFO Ian Brown received $96,341. This simplifies XpresTest's capitalization ahead of the pending $13 million sale of XpresSpa and XpresTest, and the payments will no longer reduce the purchase price at closing. The early completion with Buyer consent signals the transaction is progressing toward the shareholder vote.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.8% of the 1732 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XWEL was trading at $0.85 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $0.26 to $2.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.